Weight is one metric, but it is not the only one
Speakers covered a broad spectrum of topics related to GLP-1 RAs, including emerging pharmacological options, muscle physiology, obesity treatment for osteoarthritis (OA), and nutritional counseling
Studies show around 18.3% body weight lost at 12 months and mean losses as high as 25.5% at 18 months for specific responders
Some compounding pharmacies also offer sublingual (under-the-tongue) formulations, but these have not been extensively studied and the FDA has raised concerns about salt-form variations
While cost and insurance coverage remain the leading reasons why consumers have stopped taking a GLP-1 medication, that percentage is down from early April data
verify on the official page before purchasing